[go: up one dir, main page]

WO1999035169A3 - Methods and compositions for treating and diagnosing insulin related disorders - Google Patents

Methods and compositions for treating and diagnosing insulin related disorders Download PDF

Info

Publication number
WO1999035169A3
WO1999035169A3 PCT/US1999/000471 US9900471W WO9935169A3 WO 1999035169 A3 WO1999035169 A3 WO 1999035169A3 US 9900471 W US9900471 W US 9900471W WO 9935169 A3 WO9935169 A3 WO 9935169A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
compositions
treating
related disorders
insulin related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/000471
Other languages
French (fr)
Other versions
WO1999035169A9 (en
WO1999035169A2 (en
Inventor
William Clifford Duckworth
Frederick G Hamel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2000527564A priority Critical patent/JP2002500234A/en
Priority to CA002317674A priority patent/CA2317674A1/en
Priority to EP99903019A priority patent/EP1045860A2/en
Priority to AU23138/99A priority patent/AU2313899A/en
Priority to BR9906833-8A priority patent/BR9906833A/en
Publication of WO1999035169A2 publication Critical patent/WO1999035169A2/en
Publication of WO1999035169A3 publication Critical patent/WO1999035169A3/en
Publication of WO1999035169A9 publication Critical patent/WO1999035169A9/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to methods and compositions for treating or reducing the symptoms of a disorder of absolute or relative insulin deficiency, severe insulin resistance, of lipid accumulation or excess lipid synthesis, or of protein catabolism or degradation. The invention also includes methods for detecting and for assessing treatments of such disorders.
PCT/US1999/000471 1998-01-08 1999-01-08 Methods and compositions for treating and diagnosing insulin related disorders Ceased WO1999035169A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2000527564A JP2002500234A (en) 1998-01-08 1999-01-08 Methods and compositions for treating and diagnosing insulin-related diseases
CA002317674A CA2317674A1 (en) 1998-01-08 1999-01-08 Methods and compositions for treating and diagnosing insulin related disorders
EP99903019A EP1045860A2 (en) 1998-01-08 1999-01-08 Methods and compositions for treating and diagnosing insulin related disorders
AU23138/99A AU2313899A (en) 1998-01-08 1999-01-08 Methods and compositions for treating and diagnosing insulin related disorders
BR9906833-8A BR9906833A (en) 1998-01-08 1999-01-08 Processes and compositions to treat diagnosing insulin-related disorders

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7082198P 1998-01-08 1998-01-08
US60/070,821 1998-01-08

Publications (3)

Publication Number Publication Date
WO1999035169A2 WO1999035169A2 (en) 1999-07-15
WO1999035169A3 true WO1999035169A3 (en) 1999-10-07
WO1999035169A9 WO1999035169A9 (en) 1999-11-11

Family

ID=22097585

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/000471 Ceased WO1999035169A2 (en) 1998-01-08 1999-01-08 Methods and compositions for treating and diagnosing insulin related disorders

Country Status (7)

Country Link
EP (1) EP1045860A2 (en)
JP (1) JP2002500234A (en)
CN (1) CN1292798A (en)
AU (1) AU2313899A (en)
BR (1) BR9906833A (en)
CA (1) CA2317674A1 (en)
WO (1) WO1999035169A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465714B2 (en) 1999-11-05 2002-10-15 Arexis Ab Congenic animal models of non-insulin dependent diabetes mellitus
US20090023630A1 (en) * 2005-01-31 2009-01-22 Jan Wouter Drijfhout Methods and Means for Use in Diagnostics and Treatment of Diabetes
EP2356452B1 (en) * 2008-10-31 2019-04-24 B.R.A.H.M.S GmbH Methods and assays for classifying foodstuff and/or beverage and/or diet and/or nutrition regimen and/or medicament in view of an effect on the cardiovascular system
EP2391377A2 (en) 2009-02-02 2011-12-07 Ramot at Tel-Aviv University Ltd. Peptides, pharmaceutical compositions comprising same and uses thereof
WO2012017439A2 (en) 2010-08-04 2012-02-09 Ramot At Tel-Aviv University Ltd. Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases
CN104961706B (en) * 2015-07-06 2017-03-01 成都知普莱生物医药科技有限公司 A kind of method of insulin synthesis degraded enzyme inhibitor ML345
CN115477686B (en) * 2022-09-22 2024-01-30 北海黑珍珠海洋生物科技有限公司 Pearl shell active peptide with whitening effect and application thereof
CN119322179B (en) * 2024-09-03 2025-11-11 中日友好医院(中日友好临床医学研究所) Application of biomarker in predicting diabetes strengthening treatment effect and kit

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994023737A1 (en) * 1993-04-16 1994-10-27 Research Corporation Technologies, Inc. Methods and compositions for delaying or preventing the onset of autoimmune disease
WO1995023166A1 (en) * 1994-02-25 1995-08-31 Deakin Research Limited Synthetic inverso or retro-inverso t-cell epitopes
US5594100A (en) * 1995-02-22 1997-01-14 Regents Of The University Of Colorado Epitope for prevention of type I diabetes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994023737A1 (en) * 1993-04-16 1994-10-27 Research Corporation Technologies, Inc. Methods and compositions for delaying or preventing the onset of autoimmune disease
WO1995023166A1 (en) * 1994-02-25 1995-08-31 Deakin Research Limited Synthetic inverso or retro-inverso t-cell epitopes
US5594100A (en) * 1995-02-22 1997-01-14 Regents Of The University Of Colorado Epitope for prevention of type I diabetes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
W.C. DUCKWORTH ET AL.: "A Direct Inhibitory Effect of Insulin on a Cytosolic Proteolytic Complex Containing Insulin-degrading enzyme and Multicatalytic Proteinase", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 269, no. 40, 7 October 1994 (1994-10-07), BALTIMORE, MD US, pages 24575 - 24580, XP002111260, ISSN: 0006-291X *

Also Published As

Publication number Publication date
WO1999035169A9 (en) 1999-11-11
BR9906833A (en) 2001-11-27
JP2002500234A (en) 2002-01-08
CA2317674A1 (en) 1999-07-15
AU2313899A (en) 1999-07-26
CN1292798A (en) 2001-04-25
EP1045860A2 (en) 2000-10-25
WO1999035169A2 (en) 1999-07-15

Similar Documents

Publication Publication Date Title
WO1996018738A3 (en) PROBIN TYROSINE KINASE (PYK2) ITS cDNA CLONING AND ITS USES
WO2003055979A3 (en) ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO BLyS
WO1999024463A3 (en) Signal peptide-containing proteins
ES2159318T3 (en) INHIBITORS OF PROTEIN QUINASA C.
EP2327451A3 (en) Method for detecting and inhibiting angiogenesis
EP1903058A3 (en) Extracellular novel rage binding protein (en-rage) and uses thereof
PT1214600E (en) DETERMINATION OF PROTEINS FROM LIGACAO TO ADRENOMEDULIN
WO1999035169A3 (en) Methods and compositions for treating and diagnosing insulin related disorders
WO2000018922A3 (en) Human carbohydrate-associated proteins
WO2000020604A3 (en) Oxidoreductase molecules
WO2003031568A3 (en) Intracellular signaling molecules
WO2004009797A3 (en) Protein modification and maintenance molecules
WO1999057270A3 (en) Human receptor molecules
WO2000065054A3 (en) Human membrane-associated proteins
WO2002101008A3 (en) Intracellular signaling molecules
WO1999049037A3 (en) Protein phosphatase-related molecules
WO2003025130A3 (en) Receptors and membrane-associated proteins
WO2003100016A3 (en) Protein modification and maintenance molecules
WO2001083524A3 (en) Rna metabolism proteins
WO1999061626A3 (en) Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase
WO2001085956A3 (en) Lipid metabolism enzymes
ZA976171B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome.
WO2002016597A3 (en) Lipid metabolism enzymes
WO2000000608A3 (en) Immune system molecules
WO2002046418A3 (en) Lipid-associated molecules

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99803812.1

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C2

Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/42-42/42, DRAWINGS, REPLACED BY NEW PAGES 1/42-42/42; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

WWE Wipo information: entry into national phase

Ref document number: 23138/99

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2317674

Country of ref document: CA

Ref document number: 2317674

Country of ref document: CA

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: KR

ENP Entry into the national phase

Ref document number: 2000 527564

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1999903019

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09582693

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999903019

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999903019

Country of ref document: EP